pentobarbital will reduce the level or outcome of buprenorphine, lengthy-acting injection by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. Patients who transfer to buprenorphine extensive-acting injection from transmucosal buprenorphine coadministered with CYP3A4 inducers must be monitored to be certa